Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wild

Showing results (671-680 of 738) with videos related to

Pageof 74
Sort By:
BMC Medical Imaging|June 2, 2023
Radiomics for therapy-specific head and neck squamous cell carcinoma survival prognostication (part I)Simon Bernatz, Ines Böth, Jörg Ackermann, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 5, 2025
Head and neck tumor organoid biobank for modelling individual responses to radiation therapy according to the TP53/HPV statusChristian Issing, Constantin Menche, Mara Romero Richter, et al.
NPJ Systems Biology and Applications|August 27, 2020
Inferring clonal composition from multiple tumor biopsiesMatteo Manica, Hyunjae Ryan Kim, Roland Mathis, et al.
Scientific Reports|February 24, 2018
Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesisLars Erichsen, Foued Ghanjati, Agnes Beermann, et al.
Scientific Reports|April 13, 2018
Author Correction: Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesisLars Erichsen, Foued Ghanjati, Agnes Beermann, et al.
Acta Neuropathologica Communications|November 21, 2024
Detection of diagnostic somatic copy number alterations from cerebrospinal fluid cell-free DNA in brain tumor patientsSvenja Klinsing, Julia Beck, Katharina J Weber, et al.
Translational Neurodegeneration|October 8, 2024
Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington's disease miceNicholas S Caron, Lauren M Byrne, Fanny L Lemarié, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2014
Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomyHelle Kristensen, Christa Haldrup, Siri Strand, et al.
Molecular & Cellular Proteomics : MCP|July 11, 2019
A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian CancerRuth Hüttenhain, Meena Choi, Laura Martin de la Fuente, et al.
Nature Reviews. Neurology|March 12, 2014
Huntington disease: natural history, biomarkers and prospects for therapeuticsChristopher A Ross, Elizabeth H Aylward, Edward J Wild, et al.
Pageof 74

Showing results (671-680 of 738) with videos related to

Sort By:
Pageof 74
BMC Medical Imaging|June 2, 2023
Radiomics for therapy-specific head and neck squamous cell carcinoma survival prognostication (part I)Simon Bernatz, Ines Böth, Jörg Ackermann, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 5, 2025
Head and neck tumor organoid biobank for modelling individual responses to radiation therapy according to the TP53/HPV statusChristian Issing, Constantin Menche, Mara Romero Richter, et al.
NPJ Systems Biology and Applications|August 27, 2020
Inferring clonal composition from multiple tumor biopsiesMatteo Manica, Hyunjae Ryan Kim, Roland Mathis, et al.
Scientific Reports|February 24, 2018
Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesisLars Erichsen, Foued Ghanjati, Agnes Beermann, et al.
Scientific Reports|April 13, 2018
Author Correction: Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesisLars Erichsen, Foued Ghanjati, Agnes Beermann, et al.
Acta Neuropathologica Communications|November 21, 2024
Detection of diagnostic somatic copy number alterations from cerebrospinal fluid cell-free DNA in brain tumor patientsSvenja Klinsing, Julia Beck, Katharina J Weber, et al.
Translational Neurodegeneration|October 8, 2024
Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington's disease miceNicholas S Caron, Lauren M Byrne, Fanny L Lemarié, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2014
Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomyHelle Kristensen, Christa Haldrup, Siri Strand, et al.
Molecular & Cellular Proteomics : MCP|July 11, 2019
A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian CancerRuth Hüttenhain, Meena Choi, Laura Martin de la Fuente, et al.
Nature Reviews. Neurology|March 12, 2014
Huntington disease: natural history, biomarkers and prospects for therapeuticsChristopher A Ross, Elizabeth H Aylward, Edward J Wild, et al.
Pageof 74